NFL and NFLPA Examine Eagles’ Handling of Hurts’ Clots

The NFL and NFL Players Association are jointly examining the Philadelphia Eagles’ handling of Jalen Hurts’ blood-clot condition after he was cleared to play and later diagnosed with more serious clots. The inquiry is underway, and no findings on the team’s medical decisions have been reported. Hurts was found to have a superficial clot in his calf before the Eagles played the Jacksonville Jaguars in London. The team’s medical staff cleared him to play. Follow-up imaging later found deep vein thrombosis and blood clots in both lungs. Hurts is expected to miss the remainder of the 2026 season, according to the reports. The review is examining how the Eagles handled the condition and whether their judgment was incorrect. The reports do not establish that the decision to clear Hurts violated medical standards or that the joint inquiry has reached a conclusion. NFL chief medical officer Allen Sills defended the Eagles’ process, saying the care was cautious and that he had confidence in the timing and decisions. He cited imaging conducted in London and said he believed those involved acted with caution. A report attributed to Philadelphia Inquirer columnist Marcus Hayes said league...